Sök artiklar i SveMed+

Observera: SveMed+ upphör att uppdateras!



Behandling av osteoporose med parathyreoideahormon
Engelsk titel: Treatment of osteoporosis with parathyroid hormone Läs online Författare: Syversen U ; Halse JI Språk: Nor Antal referenser: 35 Dokumenttyp: Översikt UI-nummer: 08011138

Tidskrift

Tidsskrift for Den Norske Laegeforening 2008;128(1)39-41 ISSN 0029-2001 E-ISSN 0807-7096 KIBs bestånd av denna tidskrift Denna tidskrift är expertgranskad (Peer-Reviewed)

Sammanfattning

BACKGROUND : Until recently, antiresorptive therapy has been the only treatment of osteoporosis. Parathyroid hormone (PTH) represents a new treatment principle. PTH given intermittently stimulates the osteoblasts and bone formation. We here present the effect of PTH on bone metabolism, bone mineral density and fracture reduction, and discuss the role of PTH in osteoporosis treatment. MATERIAL AND METHODS : The article is based on literature retrieved from Pubmed/Medline and on own experience from participation in multicentre studies. RESULTS AND INTERPRETATION : Treatment with PTH stimulates bone formation and causes a more pronounced increase in bone mineral density than bisphosphonates and results in a significant reduction of vertebral and nonvertebral fractures. The treatment is very expensive, and is therefore used and reimbursed restrictively.